Intel Corp vs UnitedHealth Group Inc — how do they compare? Intel Corp trades at $104.7 (market cap $566.04B), while UnitedHealth Group Inc trades at $379.3 (market cap $332.96B). The key difference: Intel Corp is the larger of the two by market cap, and UnitedHealth Group Inc pays the higher dividend (2.5%). Which is the better fit depends on your goals — on Pluang, investors hold Intel Corp for 116 Days and UnitedHealth Group Inc for 97 Days on average.
| INTC | UNH | |
|---|---|---|
Market Cap | $566.04B | $332.96B |
Volume | 118,475,837 | 7,273,749 |
Sector | Technology | Health |
52-Week High | $140.94 | $436.35 |
52-Week Low | $33.62 | $259.02 |
Typical Hold Time | 116 Days | 97 Days |
Enterprise Value | $586.85B | $374.82B |
Dividend Yield | 2.24% | 2.5% |
Signals from Pluang's Aura AI — not financial advice
Intel (INTC) trades at $107.08, down 5.34% today, but maintains a bullish technical outlook with strong support at $104. The stock has surged over 220% year-to-date amid AI-driven momentum. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $0.42 exceeding estimates. However, the company posted a net loss of -$267 million in 2025, reflecting margin pressures. Cash flow improved with $6.46 billion net inflow in 2025, though debt levels remain elevated.
Intel's turnaround story hinges on its foundry expansion and AI chip demand, but high valuation ratios and negative profitability metrics pose risks. Analyst consensus is cautious with a $111.72 price target and 54% hold ratings. Competitive threats from TSMC and AMD require careful monitoring for sustained growth.
UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.
UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →